Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123172) titled 'Construction of a Clinical Prediction Model for Cardiotoxicity in Breast Cancer Chemotherapy and Targeted Therapy Based on Machine Learning' on April 22.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Fifth Affiliated Hospital of Zhengzhou University

Condition: cardiotoxicity

Intervention: Cardiotoxicity group:No intervention

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-10

Target Sample Size: Cardiotoxicity group:50;Non-cardiotoxicity group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.ht...